Shinsuke Nanto Selected Research

Stroke (Strokes)

2/2021	Efficacy and Safety of Prasugrel by Stroke Subtype: A Sub-Analysis of the PRASTRO-I Randomized Controlled Trial.
1/2021	Blood Pressure Level and Variability During Long-Term Prasugrel or Clopidogrel Medication After Stroke: PRASTRO-I.
1/2020	Safety and Efficacy of Prasugrel in Elderly/Low Body Weight Japanese Patients with Ischemic Stroke: Randomized PRASTRO-II.
1/2014	Introduction of point-of-care testing in Japanese outpatient clinics is associated with improvement in time in therapeutic range in anticoagulant-treated patients.
1/2012	Oral treatment with nicorandil at discharge is associated with reduced mortality after acute myocardial infarction.
1/2008	Effect of early use of low-dose pravastatin on major adverse cardiac events in patients with acute myocardial infarction: the OACIS-LIPID Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shinsuke Nanto Research Topics

Disease

27	Myocardial Infarction 01/2020 - 04/2003
13	Thrombosis (Thrombus) 01/2022 - 07/2002
12	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 05/2003
11	Chronic Limb-Threatening Ischemia 01/2022 - 05/2010
11	Neointima 10/2019 - 04/2003
10	Heart Failure 01/2022 - 10/2007
9	Diabetes Mellitus 01/2022 - 10/2007
8	Peripheral Arterial Disease 01/2022 - 07/2006
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2008
7	Ischemic Stroke 02/2021 - 01/2014
7	Hemorrhage 01/2020 - 01/2014
7	Pathologic Constriction (Stenosis) 01/2019 - 10/2005
7	ST Elevation Myocardial Infarction 06/2016 - 12/2007
6	Stroke (Strokes) 02/2021 - 01/2008
5	Hypertension (High Blood Pressure) 01/2022 - 01/2018
5	Ischemia 01/2018 - 10/2007
5	Atrial Fibrillation 10/2015 - 01/2011
5	Tachycardia (Tachyarrhythmias) 01/2014 - 01/2011
4	Infarction (Infarctions) 01/2016 - 04/2003
4	Acute Coronary Syndrome 01/2016 - 05/2011
4	Aortic Valve Stenosis (Aortic Stenosis) 01/2015 - 12/2012
3	Atherosclerotic Plaque (Atheroma) 09/2010 - 07/2002
2	Embolic Stroke 01/2019 - 04/2018
2	Myocardial Ischemia (Ischemic Heart Diseases) 04/2017 - 01/2009
2	Renal Insufficiency (Renal Failure) 01/2017 - 09/2014
2	Ventricular Tachycardia 06/2016 - 01/2014
2	Heart Arrest (Cardiac Arrest) 08/2012 - 05/2012
2	Stable Angina 05/2011 - 10/2005
2	Hyperplasia 10/2009 - 05/2006
2	Ulcer 10/2007 - 04/2003
1	Frailty 02/2022
1	Chronic Renal Insufficiency 01/2022
1	Atherosclerosis 02/2021
1	Body Weight (Weight, Body) 01/2020
1	Atrioventricular Block 03/2019
1	Antithrombin III Deficiency 03/2019
1	Thrombophilia 03/2019
1	Venous Thromboembolism 03/2019
1	Arteriovenous Fistula 01/2019
1	Vascular Remodeling 09/2018
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2018
1	Essential Hypertension 01/2018
1	Infections 01/2018
1	Chronic Kidney Failure (Chronic Renal Failure) 11/2017
1	Synovitis 10/2016
1	Edema (Dropsy) 10/2016
1	Eosinophilia 04/2016

Drug/Important Bio-Agent (IBA)

10	Clopidogrel (Plavix)FDA Link 02/2021 - 01/2014
9	Prasugrel Hydrochloride FDA Link 02/2021 - 01/2014
5	Paclitaxel (Taxol)FDA LinkGeneric 09/2018 - 01/2014
5	Sirolimus (Rapamycin)FDA Link 04/2015 - 05/2006
4	Cilostazol (Pletal)FDA LinkGeneric 03/2017 - 01/2011
4	omega-Chloroacetophenone (Mace)IBA 04/2016 - 05/2011
4	nitinolIBA 04/2014 - 07/2006
4	Nicorandil (SG 75)IBA 08/2013 - 10/2007
3	salicylhydroxamic acid (SHAM)IBA 01/2022 - 01/2018
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2015 - 09/2005
3	Atorvastatin (Lipitor)FDA Link 06/2013 - 04/2009
2	DiureticsIBA 01/2018 - 10/2016
2	Troponin T (Troponin T1)IBA 04/2016 - 12/2007
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 07/2015 - 09/2014
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2014 - 01/2014
2	MicroRNAs (MicroRNA)IBA 07/2013 - 10/2012
2	Indicators and Reagents (Reagents)IBA 01/2009 - 02/2007
2	LipidsIBA 01/2008 - 07/2002
2	C-Reactive ProteinIBA 09/2005 - 04/2003
1	Fluorocarbon PolymersIBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	ThienopyridinesIBA 01/2021
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021
1	AntithrombinsIBA 03/2019
1	apixabanIBA 03/2019
1	OligodeoxyribonucleotidesIBA 01/2019
1	Sulfates (Sulfates, Inorganic)IBA 04/2018
1	AlbuminsIBA 01/2018
1	Antihypertensive Agents (Antihypertensives)IBA 01/2018
1	Serum AlbuminIBA 01/2018
1	Pharmaceutical PreparationsIBA 03/2017
1	Carbon DioxideIBA 01/2017
1	Spironolactone (Aldactone)FDA LinkGeneric 10/2016
1	Furosemide (Lasix)FDA LinkGeneric 10/2016
1	Prednisolone (Predate)FDA LinkGeneric 10/2016

Therapy/Procedure

36	Stents 01/2022 - 04/2003
23	Percutaneous Coronary Intervention 03/2019 - 08/2003
20	Therapeutics 01/2022 - 04/2003
13	Drug-Eluting Stents 01/2022 - 04/2010
6	Catheter Ablation 10/2015 - 01/2011
4	Denervation 01/2022 - 01/2018
4	Catheters 01/2022 - 01/2018
4	Renal Dialysis (Hemodialysis) 01/2019 - 01/2012
4	Surgical Amputation (Amputations) 09/2015 - 10/2007
4	Transcatheter Aortic Valve Replacement 01/2015 - 12/2012
3	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2018 - 07/2013
2	Length of Stay 01/2018 - 10/2005
2	Secondary Prevention 01/2018 - 01/2014
2	Limb Salvage 11/2017 - 10/2007
2	Resuscitation 08/2014 - 05/2012
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2014 - 01/2014
2	Heart Transplantation (Grafting, Heart) 06/2013 - 01/2012
1	Activities of Daily Living (ADL) 02/2022